William D. Humphries
CIK 1674278 · President, Ortho-Dermatologics · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.40M
Companies
5
Total Filings
48
Lifetime Open-Market Net
-$2.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 45,105 | $4.32 | $194.9K | $0 | 13 | 2026-06-08 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 51,040 | $0.35 | $17.9K | $9.9K | 12 | 2024-06-21 |
| SSKN | Director | 109,724 | $0.15 | $16.4K | $52.8K | 5 | 2023-07-07 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 3 | 2022-06-10 |
| BHC | President, Ortho-Dermatologics | 235,035 | $5.06 | $1.19M | -$2.43M | 11 | 2020-12-08 |
Recent Filings · Page 4 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-03 | BHC | Tax (F) | −2,264 | -$55.3K | EDGAR |
| 2020-02-28 | BHC | Grant (A) | +13,506 | $0 | EDGAR |
| 2020-02-24 | BHC | Mixed | +70,162 | -$1.50M | EDGAR |
| 2020-01-07 | BHC | Tax (F) | −14,559 | -$435.6K | EDGAR |
| 2019-08-20 | BHC | Mixed | +61,406 | $650.1K | EDGAR |
| 2019-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-10 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2019-03-01 | BHC | Grant (A) | +15,221 | $0 | EDGAR |
| 2019-01-07 | BHC | Tax (F) | −13,311 | -$245.9K | EDGAR |
| 2018-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.